208 POSTER A phase II study of sunitinib, an oral multi-targeted tyrosine kinase inhibitor, in patients with unresectable, locally advanced or metastatic cervical carcinoma: IND184
| Autor: | Mackay, H., Tinker, A., Winquist, E., Thomas, G., Sederias, J., Ivy, P., Eisenhauer, E.A. |
|---|---|
| Zdroj: | In EJC Supplements 2008 6(12):66-66 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect